Nipocalimab‐aahu (IMAAVY) for Generalized Myasthenia Gravis: Redefining Treatment With FcRn Inhibition

Authors

Muhammad U. Manzoor (ORCID: https://orcid.org/0000-0002-1140-3804)
H. N. Ahmed
Reham Jamal
Muhammad Affan Abid (ORCID: https://orcid.org/0009-0002-0033-7028)

Institutions

Karachi Medical and Dental College (PK)
Dow University of Health Sciences (PK)

Publication Details

Journal: Medicine Advances
Published: 2025-12-01
DOI: https://doi.org/10.1002/med4.70043
Primary Topic: Myasthenia Gravis and Thymoma
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Nipocalimab‐aahu (IMAAVY) for Generalized Myasthenia Gravis: Redefining Treatment With FcRn Inhibition

Muhammad U. Manzoor, H. N. Ahmed, Reham Jamal, Muhammad Affan Abid

Dec 1, 2025

Medicine Advances

Myasthenia Gravis and Thymoma

article

Nipocalimab‐aahu (IMAAVY) for Generalized Myasthenia Gravis: Redefining Treatment With FcRn Inhibition

Muhammad U. Manzoor, H. N. Ahmed, Reham Jamal, Muhammad Affan Abid

December 1, 2025article en

Abstract

No abstract available for this paper.

Medicine AdvancesVol. 3(4)

Karachi Medical and Dental College (PK), Dow University of Health Sciences (PK)

Openalex Percentile: Top 45%

Myasthenia Gravis and Thymoma

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nipocalimab‐aahu (IMAAVY) for Generalized Myasthenia Gravis: Redefining Treatment With FcRn Inhibition — Muhammad U. Manzoor, H. N. Ahmed, et al. · Medicine Advances (2025) | TGRS Research Map | TGRS